Literature DB >> 31209642

Bony decompression vs duraplasty for Chiari I malformation: does the eternal dilemma matter?

Luca Massimi1,2, P Frassanito3, F Bianchi3, G Tamburrini3,4, M Caldarelli3,4.   

Abstract

PURPOSE: The management of Chiari I malformation (CIM) still raises the problem of the optimal surgical treatment, with special regard to the "eternal dilemma" of the posterior fossa bony decompression alone (PFBD) or with duraplasty (PFBDD). The goal of the present review is to update the results (outcome and complications) of both techniques to better understand the correct indication for each of them.
METHODS: A review of the literature has been performed, focusing on the articles and the meta-analyses specifically addressing the problem of PFBD vs PFBDD. Also, the personal authors' experience is briefly discussed.
RESULTS: PFBD (usually with C1 laminectomy, often with delamination of the external dural layer) is the most commonly used technique in children, especially if syringomyelia is absent. It ensures a high success rate, with > 80% clinical improvement and about 75% reduction of the syringomyelia, and a very low risk of complications, hospital stay, and costs. A certain risk of recurrence is present (2-12%). PFBDD (with autologous tissues or dural substitutes), on the other hand, is mostly used not only in adults but also in children with large syringomyelia. It is burdened by a higher risk of complications (namely, the CSF-related ones), longer hospital stay, and higher costs; however, it warrants a better clinical improvement (> 85%) and a lower risk of reoperation (2-3.5%). Eight meta-analyses of the literature (three on pediatric series and five in adult series) and one prospective study in children, published in the last decade, largely confirm these findings.
CONCLUSION: PFBD and PFBDD are different techniques that are indicated for different types of patients. In children, PFBD has been demonstrated to represent the best choice, although some patients may require a more aggressive treatment. Therefore, the success in the management of CIM, with or without syringomyelia, depends on the correct indication to surgery and on a patient-tailored choice rather than on the surgical technique.

Entities:  

Keywords:  Chiari I malformation; Craniectomy; Decompression; Duraplasty; Posterior cranial fossa

Year:  2019        PMID: 31209642     DOI: 10.1007/s00381-019-04218-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  79 in total

Review 1.  Cranio-cervical decompression for Chiari type I-malformation, adding extreme lateral foramen magnum opening and expansile duroplasty with arachnoid preservation. Technique and long-term functional results in 44 consecutive adult cases -- comparison with literature data.

Authors:  M Sindou; J Chávez-Machuca; H Hashish
Journal:  Acta Neurochir (Wien)       Date:  2002-10       Impact factor: 2.216

2.  Effects of posterior fossa decompression with and without duraplasty on Chiari malformation-associated hydromyelia.

Authors:  I Munshi; D Frim; R Stine-Reyes; B K Weir; J Hekmatpanah; F Brown
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

Review 3.  Revision surgery for Chiari malformation decompression.

Authors:  Catherine A Mazzola; Arno H Fried
Journal:  Neurosurg Focus       Date:  2003-09-15       Impact factor: 4.047

4.  Posterior atlantooccipital membrane for duraplasty. Technical note.

Authors:  R Shane Tubbs; John C Wellons; Jeffrey P Blount; W Jerry Oakes
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

5.  Recurrence of symptoms after Chiari decompression and duraplasty with nonautologous graft material.

Authors:  David S Rosen; Robert Wollman; David M Frim
Journal:  Pediatr Neurosurg       Date:  2003-04       Impact factor: 1.162

Review 6.  Chiari type I anomalies in children and adolescents: minimally invasive management in a series of 53 cases.

Authors:  L Genitori; P Peretta; C Nurisso; L Macinante; F Mussa
Journal:  Childs Nerv Syst       Date:  2000-11       Impact factor: 1.475

7.  Dura-splitting decompression of the craniocervical junction: reduced operative time, hospital stay, and cost with equivalent early outcome.

Authors:  Farhad M Limonadi; Nathan R Selden
Journal:  J Neurosurg       Date:  2004-11       Impact factor: 5.115

8.  Toward a simpler surgical management of Chiari I malformation in a pediatric population.

Authors:  M D Krieger; J G McComb; M L Levy
Journal:  Pediatr Neurosurg       Date:  1999-03       Impact factor: 1.162

9.  Surgical experience in 130 pediatric patients with Chiari I malformations.

Authors:  R Shane Tubbs; Matthew J McGirt; W Jerry Oakes
Journal:  J Neurosurg       Date:  2003-08       Impact factor: 5.115

10.  Surgical results of posterior fossa decompression for patients with Chiari I malformation.

Authors:  Ramon Navarro; Greg Olavarria; Roopa Seshadri; Gabriel Gonzales-Portillo; David G McLone; Tadanori Tomita
Journal:  Childs Nerv Syst       Date:  2004-03-12       Impact factor: 1.475

View more
  3 in total

Review 1.  Tonsillar herniation spectrum: more than just Chiari I. Update and controversies on classification and management.

Authors:  Pietro Fiaschi; Giovanni Morana; Pasquale Anania; Andrea Rossi; Alessandro Consales; Gianluca Piatelli; Armando Cama; Marco Pavanello
Journal:  Neurosurg Rev       Date:  2019-11-10       Impact factor: 3.042

2.  Outcomes of dura-splitting technique compared to conventional duraplasty technique in the treatment of adult Chiari I malformation: a systematic review and meta-analysis.

Authors:  Amin Tavallaii; Ehsan Keykhosravi; Hamid Rezaee; Mohammad Ali Abouei Mehrizi; Ahmad Ghorbanpour; Ali Shahriari
Journal:  Neurosurg Rev       Date:  2020-06-22       Impact factor: 3.042

3.  Diagnosis and treatment of Chiari malformation type 1 in children: the International Consensus Document.

Authors:  Luca Massimi; Paola Peretta; Alessandra Erbetta; Alessandra Solari; Mariangela Farinotti; Palma Ciaramitaro; Veronica Saletti; Massimo Caldarelli; Alexandre Casagrande Canheu; Carlo Celada; Luisa Chiapparini; Daniela Chieffo; Giuseppe Cinalli; Federico Di Rocco; Marika Furlanetto; Flavio Giordano; George Jallo; Syril James; Paola Lanteri; Christian Lemarchand; Martina Messing-Jünger; Cecilia Parazzini; Giovanna Paternoster; Gianluca Piatelli; Maria A Poca; Prab Prabahkar; Federica Ricci; Andrea Righini; Francesco Sala; Juan Sahuquillo; Marcus Stoodley; Giuseppe Talamonti; Dominic Thompson; Fabio Triulzi; Mino Zucchelli; Laura Valentini
Journal:  Neurol Sci       Date:  2021-06-07       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.